Subscribe to our Email Alerts
Menu
Home
About Us
Company Overview
Company Values
Board of Directors
Management
Corporate Directory
Products
DAYBUE™ (trofinetide)
Pipeline
Pipeline
Trofinetide
Rett Syndrome
Fragile X Syndrome
NNZ-2591
Phelan-McDermid Syndrome
Angelman Syndrome
Pitt Hopkins Syndrome
Prader-Willi Syndrome
Science
Science Behind Neuren's Products
Scientific Presentations
Publications
Investors
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
News & Media
Media
Contact
Contact Us
Email Alerts
Investors
Home
>
Investors
>
Annual and Interim Reports
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
Annual and Interim Reports
Neuren Pharmaceuticals (ASX:NEU)
2023 Online Annual Report
View our Annual Report
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
2017
Older
Aug 26, 2020
Half Yearly Report and Accounts
Apr 29, 2020
Annual Report 2019
Feb 26, 2020
Appendix 4E and 2019 full year accounts
1
